Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Tysabri: no longer out of TOUCH in the US

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Tysabri: no longer out of TOUCH in the US. React. Wkly. 1106, 3 (2006). https://doi.org/10.2165/00128415-200611060-00006

    Download citation

    Keywords

    • Multiple Sclerosis
    • Progressive Multifocal Leukoencephalopathy
    • Natalizumab
    • Progressive Multifocal Leukoencephalopathy
    • Risk Management Plan